Skip to main content
Clinical Trials/NCT02279550
NCT02279550
Recruiting
Not Applicable

Institutional Registry of Hip Fracture in the Elderly

Hospital Italiano de Buenos Aires1 site in 1 country2,000 target enrollmentNovember 2016
ConditionsHip Fracture

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip Fracture
Sponsor
Hospital Italiano de Buenos Aires
Enrollment
2000
Locations
1
Primary Endpoint
mortality
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to create an institutional and population-based registry of Hip fracture in the elderly with a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival.

Detailed Description

All patients over 65 years old who are admitted to the orthopedic and traumatology ward diagnosed with hip fracture will be assessed. The generation of the list of potentially evaluable patients will be performed daily. Once defined patient inclusion, an intern take oral informed consent and will proceed to complete the CRF. Cohort will be followed at 3 months and a second follow-up at year. Variables to be measured: Patient Data Comorbidities Charlson score Scales functionality Factors prior to the fall Medications Trauma variables Complications Mortality

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
December 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Javier Alberto Benchimol

MD

Hospital Italiano de Buenos Aires

Eligibility Criteria

Inclusion Criteria

  • Patients over 65 with hip fracture.
  • Admission to HIBA
  • Followed by any health care provider. -

Exclusion Criteria

  • 1 Patient refuses to participate in the registration or informed consent process

Outcomes

Primary Outcomes

mortality

Time Frame: 1 year

Secondary Outcomes

  • frailty (measured by the Rockwood Scale)(1 year)

Study Sites (1)

Loading locations...

Similar Trials